Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioTelemetry, Inc. (NASDAQ: BEAT).

Full DD Report for BEAT

You must become a subscriber to view this report.


Recent News from (NASDAQ: BEAT)

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors
MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that Stephan Rietiker has been elected to BioTelemetry’s Board of Directors. Dr. Rietiker was most recently the Chief Executive Officer of LifeWatch AG, until it was acquired by BioTel...
Source: GlobeNewswire
Date: November, 07 2018 16:49
New Research: Key Drivers of Growth for FleetCor Technologies, Materion, BioTelemetry, Northrop Grumman, Taubman Centers, and Sabre - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of FleetCor Technologies, Inc. (NYSE:FLT), Materion Corporation (NYSE:MTR...
Source: GlobeNewswire
Date: November, 02 2018 08:45
BioTelemetry up 15% after Q3 beat, guidance raise
BioTelemetry ( BEAT +15.2% ) is up on almost double normal volume after posting Q3 results after the close yesterday. Highlights: More news on: BioTelemetry, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: October, 31 2018 11:49
BioTelemetry, Inc. (BEAT) CEO Joseph Capper on Q3 2018 Results - Earnings Call Transcript
BioTelemetry, Inc. (BEAT) Q3 2018 Earnings Conference Call October 30, 2018, 05:00 PM ET Executives Joseph Capper - President & CEO Heather Getz - CFO Analysts Bruce Nudell - SunTrust Brooks O'Neil - Lake Street Capital Marco Rodriguez - Stonegate Capital Markets De...
Source: SeekingAlpha
Date: October, 30 2018 22:35
BioTelemetry beats by $0.21, beats on revenue
BioTelemetry (NASDAQ: BEAT ): Q3 Non-GAAP EPS of $0.53 beats by $0.21 ; GAAP EPS of $0.45 beats by $0.26 . More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 30 2018 16:13
BioTelemetry, Inc. Reports Third Quarter 2018 Financial Results
Company’s Results Exceed Expectations Company Raises Full-Year Guidance MALVERN, Pa., Oct. 30, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve q...
Source: GlobeNewswire
Date: October, 30 2018 16:05
Notable earnings after Tuesday's close
ACGL , AEGN , AFG , AINV , AMGN , APAM , APC , BAND , BEAT , BGS , BHE , BIDU , BJRI , BXP , CAI , CAKE , CHRW , CLVS , CONE , CRAY , CW , CXO , DDD , DENN , EA , EBAY , EIX , ESIO , EVTC , EXAS , EXR , FB , FEYE , FLT , GNW , H , HABT , HCLP , HLF , ...
Source: SeekingAlpha
Date: October, 29 2018 17:35
Innovative Diagnostic Technology Playing Significant Role in Improving Detection for Better Cardiac Care
Palm Beach, FL – (September 5, 2018) – Heart disease is one of the leading causes of death in the western world. In Europe and the U.S. alone, it is estimated 15 to 20 million patients a year visit the emergency departments of hospitals reporting chest pain that could be a sign of ...
Source: MarketNewsUpdates.com
Date: September, 05 2018 08:13
Analysis: Positioning to Benefit within BioTelemetry, Genworth Financial, Power Integrations, Phibro Animal Health, BlackRock, and The ExOne - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BioTelemetry, Inc. (NASDAQ:BEAT), Genworth Financial, Inc. (NYSE:GNW), Po...
Source: GlobeNewswire
Date: August, 06 2018 08:00
Mobile Cardiac Telemetry- Heart-Felt Buys
Mobile cardiac telemetry (MCT) technology is helping improve the odds for over five million Americans that suffer from irregular heart rhythms. Globally, the market is valued at roughly $22 billion, explains Tyler Laundon , editorial of the highly specialized Cabot Small Cap Confidential ...
Source: MoneyShow.com
Date: July, 30 2018 01:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0860.2060.1561.4059.65256,416
2018-05-1740.8541.2041.3540.60246,400
2017-02-0223.0023.3523.5522.8825318,137
2017-02-0123.2023.1023.2522.85227,069
2017-01-3122.1523.0523.1521.90341,333

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1825,36196,79326.2013Cover
2018-12-17110,342307,05135.9360Short
2018-12-1443,61374,56658.4891Short
2018-12-1335,05068,26451.3448Short
2018-12-1269,484120,18857.8128Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BEAT.


About BioTelemetry, Inc. (NASDAQ: BEAT)

Logo for BioTelemetry, Inc. (NASDAQ: BEAT)

Not available

 

Contact Information

 

 

Current Management

  • Arie Cohen / President, CEO

Current Share Structure

  • Market Cap: $1,019,033,379 - 05/14/2018
  • Issue and Outstanding: 25,380,657 - 04/25/2013

 


Recent Filings from (NASDAQ: BEAT)

Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 22 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 22 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 22 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 08 2018

 

 


Daily Technical Chart for (NASDAQ: BEAT)

Daily Technical Chart for (NASDAQ: BEAT)


Stay tuned for daily updates and more on (NASDAQ: BEAT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BEAT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BEAT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BEAT and does not buy, sell, or trade any shares of BEAT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/